Nottingham, UK - Angiogenesis and inflammation are central players in the osteoarthritis (OA) disease process, and inhibiting both processes might alter OA progression, according to a review article ...
Patients with type 2 diabetes and inflammatory arthritis who received GLP-1 RAs had lower rates of hypoglycemia, serious infections, and acute kidney injury vs those receiving SGLT2 inhibitors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results